Abstract
The relation between genetic variation of the androgen metabolism and transsexualism is unknown. In a case-control study of 100 male-to-female (MtF) transsexuals, 47 female-to-male (FtM) transsexuals, and 1670 controls, the authors assess allele and genotype frequencies of the steroid 5- α reductase (SRD5A2) Val89Leu polymorphism using polymerase chain reaction. Allele and genotype frequencies are not significantly di ferent between MtF transsexuals and male controls (SRD5A2 V: 137/200 [69%] and SRD5A2 L: 63/200 [31%] vs 1065/1510 [71%] and 445/1510 [29%], respectively; P =.6; odds ratio [OR], 1.10; 95% confidence interval [CI], 0.76–1.58; SRD5A2 V/V + V/L: 92/100 [92%] and L/L 8/100 [8%] vs SRD5A2 683/755 [91%] and 72/755 [9%], respectively, P =.7; OR, 0.82; 95% CI, 0.24–2.84). Allele and genotype frequencies are also not significantly di ferent between FtM transsexuals and female controls (SRD5A2 V: 70/94 [74%] and SRD5A2 L: 24/94 [26%] vs 1253/1830 [69%] and 573/1830 [31%], respectively; P =.3; OR, 0.75; 95% CI, 0.45–1.26; SRD5A2 V/V + V/L: 44/47 [93%] and L/L 3/47 [7%] vs 823/915 [90%] and 92/915 [10%], respectively, P =.6; OR, 0.61; 95% CI, 0.11–3.32). Of note, there is no gender-specific genotype distribution among controls. The SRD5A2 Val89Leu SNP is not associated with transsexualism, refuting SRD5A2 as a candidate gene of transsexualism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.Washington, DC:American Psychiatric Association; 1994.
Brown GR A review of clinical approaches to gender dysphoria. J Clin Psychiatry. 1990;51:57–64.
Dorner G., Poppe I., Stahl F., Kolzsch J., Uebelhack R. Gene-and environment-dependent neuroendocrine etiogenesis of homosexuality and transsexualism. Exp Clin Endocrinol. 1991;98:141–150.
Zhou JN, Hofman MA, Gooren Ljg, Swaab DF A sex difference in the human brain and its relation to transsexuality. Nature. 1995;378:68–70.
Labrie F., Sugimoto Y., Luu-The V., et al. Structure of human type II 5 alpha-reductase gene. Endocrinology. 1992;131: 1571–1573.
Yang C., Hamajima N., Iwata H., et al. A49T, V89L and TA repeat polymorphisms of steroid 5-alpha-reductase type II and breast cancer risk in Japanese women. Breast Cancer Res. 2002;4(4):R8.
van Gils CH, Onland-Moret NC, Roest M., van Noord PA, Peeters PH The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1194–1199.
Nam RK, Toi A., Vesprini D., et al. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology. 2001;75:199–204.
Lunn RM, Bell DA, Mohler JL, Taylor JA Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis. 1999;20:1727–1731.
Tempfer CB, Riener E., Hefler LA, Huber JC, Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril. 2004;82:132–137.
Huber M., Mundlein A., Dornstauder E., et al. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Ann Biochem. 2002;303:25–33.
Cohen-Kettenis PT, Gooren Ljg. Transsexualism: a review of etiology, diagnosis, and treatment. J Psychosom Res. 1999;46: 315–333.
Landen M., Walinder J., Lundstrom B. Prevalence, incidence and sex ratio of transsexualism. Acta Psychiatr. 1996;93:221–223.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bentz, EK., Schneeberger, C., Hefler, L.A. et al. A Common Polymorphism of the SRD5A2 Gene and Transsexualism. Reprod. Sci. 14, 705–709 (2007). https://doi.org/10.1177/1933719107306230
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719107306230